Chemical Structure (Pioglitazone 01)
Pioglitazone And Glimepiride Tablet
Product Images NDC 66993-821
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Pioglitazone And Glimepiride (NDC 66993-821). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Prasco Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chemical Structure (Pioglitazone 02)
Principal Display Panel (30/2 mg Tablet Bottle Label)
This is a medication package insert for Lyprasco MR, a tablet containing Pioglitazone 30mg and Glimepiride 2mg. The drug should be kept out of reach of children, stored at 25°C, and dispensed in a light-resistant container to protect from moisture and humidity. The usual dosage should be followed as listed on the package insert. A medication guide is available within the package. The drug is distributed by Prasco Laboratories in Mason, Ohio, and is a product of Japan. The NDC number is 66993-821-30-5.*
Principal Display Panel (30/4 mg Tablet Bottle Label)
This text is a medication label for Pioglitazone 30mg and Glimepiride 4mg tablets. The label provides instructions on dosage, storage, and precautions, and cautions against allowing children access to the medication. It also lists the manufacturer of the medicine as Prasco Laboratories and the product origin as Japan. A medication guide is included in the package insert, which must be dispensed with the medication.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
